<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Chronic Lymphocytic Leukemia

descriptionPublicationkeyboard_double_arrow_right Article 01 Oct 1999Publisher:Oxford University Press (OUP)Journal:The Oncologist, volume 4, pages 352-369 (issn: 1083-7159, eissn: 1549-490X,

Authors: Bruce D. Cheson; Nelson Kalil;

doi: 10.1634/theoncologist.4-5-352

pmid: 10551552

Chronic Lymphocytic Leukemia

- Summary
- Subjects
- Metrics

Abstract

AbstractThe diagnosis and management of chronic lymphocytic leukemia (CLL) is reviewed, including the basic aspects of epidemiology, molecular biology, and cytogenetics with clinical relevance. The importance of immunophenotype in the differential diagnosis of other lymphoproliferative disorders related to CLL, staging, prognostic factors, promising new drugs, and approaches is summarized.

Related Organizations

National Cancer Institute
United States

Keywords

Diagnosis, Differential, Humans, Leukemia, Lymphocytic, Chronic, B-Cell

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	35
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%